BIO-key International financials
$3.12+85.71%
Close Sep 29, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Quarter | Q2 '26 Jun 30 | Q1 '26 Mar 31 | Q4 '25 Dec 31 | Q3 '25 Sep 30 | Q2 '25 Jun 30 | Q1 '25 Mar 31 | Q4 '24 Dec 31 | Q3 '24 Sep 30 | Q2 '24 Jun 30 | Q1 '24 Mar 31 | Q4 '23 Dec 31 | Q3 '23 Sep 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.9M | $2.1M | $1.1M | $1.5M | $1.7M | $1.6M | $1.5M | $2.1M | $1.1M | $2.2M | $1.8M | $1.8M |
| Gross profit | $1.7M | $1.8M | $812.4K | $1.2M | $1.2M | $1.3M | $1.2M | $1.7M | $879.0K | $1.9M | -$95.5K | $340.5K |
| Gross margin | 87.2% | 82.5% | 75.0% | 76.9% | 72.6% | 82.6% | 82.1% | 78.3% | 77.0% | 86.3% | −5.2% | 18.7% |
| Operating income | -$529.4K | -$157.7K | -$4.2M | -$892.2K | -$1.1M | -$640.6K | -$1.3M | -$580.4K | -$1.7M | -$508.9K | -$2.7M | -$2.0M |
| Net income | -$576.9K | -$205.0K | -$4.3M | -$964.8K | -$1.2M | -$736.5K | -$1.4M | -$739.0K | -$1.7M | -$510.3K | -$2.4M | -$1.8M |
| Net margin | −30.0% | −9.6% | −395.8% | −62.3% | −68.8% | −45.8% | −94.7% | −34.5% | −146.1% | −23.4% | −130.0% | −101.1% |
| Diluted EPS | $-0.56 | $-0.20 | — | $-1.50 | $-2.01 | $-1.57 | $-4.51 | $-3.90 | $-10.00 | $-3.20 | $-37.50 | $-32.20 |
| EBITDA | -$495.3K | -$47.0K | -$1.8M | -$772.1K | -$1.0M | -$496.1K | -$1.3M | -$431.1K | -$1.4M | -$446.5K | -$2.5M | -$1.9M |
| Operating cash flow | -$845.7K | -$358.0K | -$1.8M | -$1.1M | -$880.0K | -$835.3K | -$514.6K | -$1.3M | -$1.4M | $297.1K | -$1.5M | -$166.7K |
| Free cash flow | -$845.7K | -$358.0K | -$1.8M | -$1.1M | -$881.5K | -$839.9K | -$524.6K | -$1.3M | -$1.4M | $295.2K | -$1.5M | -$166.7K |
| Diluted shares | 1.0M | 1.0M | — | 0.7M | 0.6M | 0.5M | 0.3M | 0.2M | 0.2M | 0.2M | 0.1M | 0.1M |
Balance sheet
| Period end | Jun 30 | Mar 31 | Dec 31 | Sep 30 | Jun 30 | Mar 31 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $1.4M | $2.2M | $2.7M | $2.0M | $2.3M | $3.1M |
| Short-term investments | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Total debt | $712.1K | $664.3K | $654.6K | $1.4M | $572.7K | $912.5K |
| Total assets | $7.5M | $8.2M | $8.3M | $10.1M | $10.5M | $11.2M |
| Total liabilities | $3.1M | $3.3M | $3.2M | $4.1M | $3.7M | $3.7M |
| Shareholders' equity | $4.3M | $4.9M | $5.1M | $6.0M | $6.9M | $7.5M |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology